Evidence map›Paper›PMID 41116863›Full record

ArticleClinical, cosmetic and investigational dermatology2025

HaiTang Heji Formula for Moderate Rosacea Refractory to Conventional Therapies: A Case Report Demonstrating Holistic Improvement in Physical and Psychological Symptoms.

Xu Liu, Yu Wang, Yanbing Han, Qingfeng Liu, Linghong Guo, Xian Jiang

Abstract readCase Reports
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xu Liu *Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID 0009-0003-7620-7323
Yu Wang *Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Yanbing Han *Sichuan Hamilton Medical Cosmetology Hospital, Chengdu, People's Republic of China.
Qingfeng LiuDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Linghong GuoDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID 0000-0002-9248-5070
Xian JiangDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.ORCID 0000-0001-5109-6055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosacea is a chronic inflammatory skin disease that significantly impacts patients' quality of life. Current treatments have limitations. We report a case of moderate papulopustular rosacea effectively treated with the Chinese herbal formula HaiTang Heji. A 34-year-old Asian woman with a 3-year history of recurrent facial erythema, papules, pustules, and flushing, refractory to conventional therapies, showed significant improvement after 16 weeks of HaiTang Heji 20mL tid. Investigator Global Assessment (IGA) decreased from 3 to 1, Global Flushing Severity Scale (GFSS) from 3 to 1, anxiety scores decreased from moderate to mild levels, and depression scores decreased from mild to minimal levels. The patient tolerated the treatment well with no reported adverse effects, highlighting the potential safety of this herbal formula. Response was largely maintained at 21-week follow-up. HaiTang Heji's therapeutic mechanisms may involve anti-inflammatory, immunomodulatory, anti-angiogenic, and gut-brain-skin axis modulation. Further research is warranted to confirm its efficacy and safety as an alternative rosacea treatment.

Indexed as

case reportChinese herbal medicineflushingHaiTang Hejiquality of liferosaceaTripterygium hypoglaucum

Identifiers

PMID41116863
PMCPMC12535717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.